Basic Information
| LncRNA/CircRNA Name | ABHD11-AS1 |
| Synonyms | ABHD11-AS1, LINC00035, NCRNA00035, WBSCR26 |
| Region | GRCh38_7:73735038-73736158 |
| Ensemble | ENSG00000225969 |
| Refseq | NR_026690 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR, RNAi, Flow cytometry assay, CCK-8 assay, MTT assay etc. |
| Sample | bladder cancer tissues, cell lines (T24, 5637, SW780) |
| Expression Pattern | up-regulated |
| Function Description | ABHD11-AS1 was up-regulated in bladder cancer tissues and cell lines, and ABHD11-AS1 expression level was positively associated with clinicobiological features. Cell proliferation, cell migration and apoptosis were observed by silencing ABHD11-AS1 and overexpression ABHD11-AS1 caused contrary effects. |
| Pubmed ID | 28157695 |
| Year | 2017 |
| Title | Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer. |
External Links
| Links for ABHD11-AS1 | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |